The prevalence and correlates of self‐reported cannabis use for medicinal, dual and recreational motives in Australia: Findings from the National Drug Strategy Household Survey 2022/2023

Abstract Introduction: Cannabis has been prescribed as a medicine in Australia since 2016. The current study aimed to conduct a descriptive, epidemiological investigation on the prevalence and correlates of cannabis use for different motives (recreational‐only, medical‐only or dual‐use) in Australia. It also aimed to examine the correlates of different cannabis use motives. Methods: The National Drug Strategy Household Survey 2022/2023 was used to estimate the prevalence and correlates of cannabis use motives among Australians. Prevalence estimates were weighted to the